CP-467688
Chemical Name: N-[2-[6-[4'-(Trifluoromethyl)biphenyl-2-ylcarboxamido]-1,2,3,4-tetrahydroisoquinolin-2-yl]ethyl]carbamic acid methyl ester hydrochloride
CAS No. 208590-81-2 (free base)
项目整合开发状态: Preclinical
项目研究机构: Pfizer (Originator)
合成路线:Condensation of 2-chloro-4-nitrobenzoic acid (I) with dimethyl malonate produced the arylmalonate (II).This was subjected to hydrolysis and subsequent decarboxylation to afford diacid (III).Conversion of (III) to the cyclic anhydride (IV) upon refluxing with Ac2O,and then reduction with borane in THF gave rise to diol (V).Optionally,diol (V) was obtained by direct reduction of diacid (III) with borane.Nitro diol (V) was reduced to amine (VI) by hydrogenation over Pt/C.This was condensed with acid chloride (VIII) (prepared from carboxylic acid (VII) and SOCl2) to afford amide (IX).After conversion to dimesylate (X),cyclization with N-acetyl ethylenediamine (XI) furnished the tetrahydroisoquinoline (XII).Acidic hydrolysis of the acetamido group of (XIV) gave primary amine (XIII) which was finally treated with methyl chloroformate to furnish the title carbamate.
📌 参考资料/链接:
参考文献标题:Apo B-secretion/MTP inhibitory amides
文献作者:Chang,G.; Quallich,G.J.(Pfizer Inc.)
参考来源:EP 0944602; JP 2000505810; WO 9823593